374 related articles for article (PubMed ID: 11394572)
1. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
[TBL] [Abstract][Full Text] [Related]
2. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
3. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
[TBL] [Abstract][Full Text] [Related]
4. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
[TBL] [Abstract][Full Text] [Related]
5. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
6. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
[TBL] [Abstract][Full Text] [Related]
7. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
Zhou YH; Sugitani M; Esumi M
Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
[TBL] [Abstract][Full Text] [Related]
9. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes.
Bartosch B; Bukh J; Meunier JC; Granier C; Engle RE; Blackwelder WC; Emerson SU; Cosset FL; Purcell RH
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14199-204. PubMed ID: 14617769
[TBL] [Abstract][Full Text] [Related]
10. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
[TBL] [Abstract][Full Text] [Related]
12. Conformational epitopes detected by cross-reactive antibodies to envelope 2 glycoprotein of the hepatitis C virus.
Nakano I; Fukuda Y; Katano Y; Hayakawa T
J Infect Dis; 1999 Oct; 180(4):1328-33. PubMed ID: 10479166
[TBL] [Abstract][Full Text] [Related]
13. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
14. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection.
Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M
Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481
[TBL] [Abstract][Full Text] [Related]
16. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
17. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
[TBL] [Abstract][Full Text] [Related]
18. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
[TBL] [Abstract][Full Text] [Related]
20. Evolutionary study of hepatitis C virus envelope genes during primary infection.
Chen S; Wang YM
Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
